Clinical Trials Directory

Trials / Completed

CompletedNCT04893200

Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung Adenocarcinoma

Could Radiomics Predict Tumor Spread Through Air Space in Lung Adenocarcinoma in All Computed Tomography Settings?

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
University of Roma La Sapienza · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Spread through air space (STAS) has been reported as a negative prognostic factor in patients with lung cancer undergone sublobar resection. Its preoperative assessment could thus be useful to customize surgical treatment. Radiomics has been recently proposed to predict STAS in patients with lung adenocarcinoma. However, all the studies have strictly selected both imaging and patients, leading to results hardly applicable to daily clinical practice. The aim of this study is to test a radiomics-based prediction model of STAS in practice-based dataset and verify its validity and translational potentials. Radiological and clinical data from 100 consecutive patients with resected lung adenocarcinoma were retrospectively collected for the training section. As in common clinical practice, preoperative CT images were acquired independently by different physicians and from different hospitals. Therefore, our dataset presents high variance in model and manufacture of scanner, acquisition and reconstruction protocol, endovenous contrast phase and pixel size. To test the effect of normalization in highly varying data, preoperative CT images and tumor region of interest were preprocessed with four different pipelines. Features were extracted using pyradiomics and selected considering both separation power and robustness within pipelines. After that, a radiomics-based prediction model of STAS were created using the most significant associated features. This model were than validated in a group of 50 patients prospectively enrolled as external validation group to test its efficacy in STAS prediction.

Conditions

Timeline

Start date
2020-02-01
Primary completion
2020-07-01
Completion
2021-06-01
First posted
2021-05-19
Last updated
2021-09-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04893200. Inclusion in this directory is not an endorsement.